Dr Michael Shurin
Professor of Pathology
University of Pittsburgh Medical Center
After graduation from Moscow State Medical School in 1984, postgraduation training in clinical biochemistry and clinical immunology and obtaining his PhD degree in Immunopharmacology in 1991, Dr. Shurin joined the faculty of the Department of Pathology at the University of Pittsburgh Medical Center in 1991 where he is a Professor of Pathology and Immunology and a Medical Director of the Division of Clinical Immunopathology. His main research interests are in the field of the tumor microenvironment, cancer-mediated immunomodulation, dendritic cell vaccines and tumor innervation. Professor Shurin’s pioneering studies on the immunobiology of dendritic cells in cancer opened opportunities for developing novel therapeutic approaches that are based on the protection of dendritic cell vaccines from tumor-mediated immunosuppression and polarization. At present, Shurin’s research program focuses on the immune modulating properties of chemotherapy and modulation of the tumor microenvironmental elements, including dendritic cells, regulatory T cells, myeloid-derived suppressor cells, nanodelivery of chemotherapy, as well as intratumoral neuroimmune network. Professor Shurin is the author of >200 peer-reviewed publications and numerous reviews, an editor of several books, including “Dendritic Cell in Cancer”, “Infection and Cancer” and “The tumor immunoenvironment”, an organizer of several popular International conferences on Immune-Mediated Diseases, Immunodiagnostics and Immunomonitoring and Cancer Immunotherapy. He is a member of several grant review and editorial boards and many clinical and research societies.